Bristol-Myers Squibb Co (BMY)

58.00 +0.24 (+0.42%) USD  |  NYSE  |  Dec 26, 16:00
58.01 +0.01 (+0.02%) After-Hours: 18:41
More

Bristol-Myers Squibb Cash and Short Term Investments (Annual): 12.28B for Dec. 31, 2023

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for BMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Amgen Inc 10.94B
Johnson & Johnson 22.93B
Eli Lilly and Co 2.928B
Merck & Co Inc 7.093B
Pfizer Inc 12.69B